NO320635B1 - Fremgangsmate for permeabilisering og identifisering av erytrocytter og sett for permeabilisering og immunisering derav. - Google Patents
Fremgangsmate for permeabilisering og identifisering av erytrocytter og sett for permeabilisering og immunisering derav. Download PDFInfo
- Publication number
- NO320635B1 NO320635B1 NO19993380A NO993380A NO320635B1 NO 320635 B1 NO320635 B1 NO 320635B1 NO 19993380 A NO19993380 A NO 19993380A NO 993380 A NO993380 A NO 993380A NO 320635 B1 NO320635 B1 NO 320635B1
- Authority
- NO
- Norway
- Prior art keywords
- erythrocytes
- fetal
- oligosaccharide
- permeabilization
- erythrocyte
- Prior art date
Links
- 210000003743 erythrocyte Anatomy 0.000 title claims description 76
- 238000000034 method Methods 0.000 title claims description 44
- 230000008823 permeabilization Effects 0.000 title claims description 20
- 230000008569 process Effects 0.000 title description 3
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 230000001605 fetal effect Effects 0.000 claims description 37
- 239000000427 antigen Substances 0.000 claims description 17
- 229920001542 oligosaccharide Polymers 0.000 claims description 16
- 150000002482 oligosaccharides Chemical class 0.000 claims description 16
- 239000004094 surface-active agent Substances 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 102000036639 antigens Human genes 0.000 claims description 12
- 108091007433 antigens Proteins 0.000 claims description 12
- 239000008191 permeabilizing agent Substances 0.000 claims description 12
- 108010044495 Fetal Hemoglobin Proteins 0.000 claims description 11
- 210000004027 cell Anatomy 0.000 claims description 11
- -1 aliphatic aldehyde Chemical class 0.000 claims description 10
- 239000000834 fixative Substances 0.000 claims description 8
- 239000003599 detergent Substances 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 4
- 238000002372 labelling Methods 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims 1
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000523 sample Substances 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 5
- FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010004729 Phycoerythrin Proteins 0.000 description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 210000004700 fetal blood Anatomy 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 208000002903 Thalassemia Diseases 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000004163 cytometry Methods 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical class O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 108060006184 phycobiliprotein Proteins 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100454807 Caenorhabditis elegans lgg-1 gene Proteins 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Ecology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809006A FR2781055B1 (fr) | 1998-07-09 | 1998-07-09 | Reactif et methode pour la permeabilisation et l'identification des erythrocytes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO993380D0 NO993380D0 (no) | 1999-07-08 |
| NO993380L NO993380L (no) | 2000-01-10 |
| NO320635B1 true NO320635B1 (no) | 2006-01-02 |
Family
ID=9528613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19993380A NO320635B1 (no) | 1998-07-09 | 1999-07-08 | Fremgangsmate for permeabilisering og identifisering av erytrocytter og sett for permeabilisering og immunisering derav. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6534279B1 (de) |
| EP (1) | EP0971233B1 (de) |
| JP (1) | JP2000039433A (de) |
| AT (1) | ATE225936T1 (de) |
| AU (1) | AU754271B2 (de) |
| DE (1) | DE69903380T2 (de) |
| DK (1) | DK0971233T3 (de) |
| ES (1) | ES2184399T3 (de) |
| FR (1) | FR2781055B1 (de) |
| NO (1) | NO320635B1 (de) |
| NZ (1) | NZ336635A (de) |
| PT (1) | PT971233E (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10010959A1 (de) * | 2000-03-06 | 2001-09-20 | Eppendorf Geraetebau Netheler | Verfahren zum Übertragen von Material in einem Zellsystem |
| ATE360213T1 (de) * | 2001-09-04 | 2007-05-15 | Iq Corp B V | Bestimung und quantifizierung von erythrocytenpopulationen in proben |
| US20040214243A1 (en) * | 2003-04-25 | 2004-10-28 | Beckman Coulter, Inc. | Differential determination of hemoglobins |
| US7803523B2 (en) | 2004-08-27 | 2010-09-28 | University Health Network | Whole blood preparation for cytometric analysis of cell signaling pathways |
| US7541190B2 (en) * | 2005-02-07 | 2009-06-02 | Beckman Coulter, Inc. | Method of measurement of cellular hemoglobin |
| CN100465642C (zh) * | 2007-07-18 | 2009-03-04 | 清华大学 | 提高环境样品免疫检测抗基质效应的方法及其专用缓冲溶液 |
| US7968279B2 (en) * | 2008-08-13 | 2011-06-28 | Beckman Coulter, Inc. | Reference control for cell by cell analysis |
| WO2019060687A1 (en) | 2017-09-21 | 2019-03-28 | Beckman Coulter, Inc. | METHOD FOR DETERMINING RED FETAL GLOBULES IN MATERNAL CIRCULATION BY FLOW CYTOMETRY |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751179A (en) * | 1984-05-31 | 1988-06-14 | Coulter Electronics, Inc. | Method and reagents for differential determination of four populations of leukocytes in blood |
| FR2571498B1 (fr) * | 1984-10-04 | 1988-04-08 | Immunotech Sa | Procede de separation de cellules utilisant des anticorps et des billes de faible densite |
| US5246829A (en) * | 1984-10-04 | 1993-09-21 | Immunotech | Products for separation applicable to cells in the immunopurification field |
| US5563033A (en) * | 1985-10-22 | 1996-10-08 | The University Of Massachusetts Medical Center | Detection of individual gene transcription |
| JPH01100454A (ja) * | 1987-09-18 | 1989-04-18 | E I Du Pont De Nemours & Co | 試験結果報告を制御する免疫スイッチ |
| NZ230747A (en) * | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| US5102788A (en) * | 1988-11-21 | 1992-04-07 | Hygeia Sciences, Inc. | Immunoassay including lyophilized reactant mixture |
| US5641628A (en) * | 1989-11-13 | 1997-06-24 | Children's Medical Center Corporation | Non-invasive method for isolation and detection of fetal DNA |
| US5853986A (en) * | 1990-04-02 | 1998-12-29 | Becton Dickinson And Company | Chemical promotion of nucleic acid hybridization |
| IE76319B1 (en) * | 1990-07-23 | 1997-10-22 | Becton Dickinson Co | Preservation of cells as controls or standards in cellular analysis |
| US5413732A (en) * | 1991-08-19 | 1995-05-09 | Abaxis, Inc. | Reagent compositions for analytical testing |
| EP0603266B1 (de) * | 1991-08-23 | 1999-05-12 | Molecular Probes, Inc. | Verwendung von haloalkylderivaten von reportermolekülen zur analyse der metabolischen aktivität in zellen |
| US5576424A (en) * | 1991-08-23 | 1996-11-19 | Molecular Probes, Inc. | Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells |
| US5998483A (en) * | 1991-09-20 | 1999-12-07 | Camiener; Gerald W. | Glyoxal-containing preservative compositions |
| US5629147A (en) * | 1992-07-17 | 1997-05-13 | Aprogenex, Inc. | Enriching and identifying fetal cells in maternal blood for in situ hybridization |
| US5596090A (en) * | 1992-07-24 | 1997-01-21 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human VCAM-1 RNA |
| US5691160A (en) * | 1992-08-14 | 1997-11-25 | Biogen, Inc. | Effects of actin filaments of fibrin clot structure and lysis |
| US5457024A (en) * | 1993-01-22 | 1995-10-10 | Aprogenex, Inc. | Isolation of fetal erythrocytes |
| FR2705360B1 (fr) * | 1993-05-19 | 1995-08-18 | Immunotech Sa | Méthode et composition pour la lyse des érythrocytes, composition de sang, et méthode d'analyse leucocytaire. |
| FR2705359B1 (fr) * | 1993-05-19 | 1995-08-18 | Immunotech Sa | Méthode de protection des cellules leucocytaires, composition protectrice, composition de sang protégée, et méthode d'analyse sanguine. |
| US5352613A (en) * | 1993-10-07 | 1994-10-04 | Tafas Triantafillos P | Cytological screening method |
| US5459268A (en) * | 1993-10-25 | 1995-10-17 | Molecular Probes, Inc. | Xanthylium dyes that are well retained in mitochondria |
| US5432054A (en) * | 1994-01-31 | 1995-07-11 | Applied Imaging | Method for separating rare cells from a population of cells |
| US5662813A (en) * | 1994-10-21 | 1997-09-02 | Bioseparations, Inc. | Method for separation of nucleated fetal erythrocytes from maternal blood samples |
| US5750339A (en) * | 1994-11-30 | 1998-05-12 | Thomas Jefferson University | Methods for identifying fetal cells |
| US5858667A (en) * | 1996-09-06 | 1999-01-12 | Litron Laboratories | Method for the enumeration of micronucleated erythrocyte populations with a single laser flow cytometer |
| US5731156A (en) * | 1996-10-21 | 1998-03-24 | Applied Imaging, Inc. | Use of anti-embryonic hemoglobin antibodies to identify fetal cells |
| US5962234A (en) * | 1997-10-20 | 1999-10-05 | Applied Imaging Corporation | Use of anti-embryonic epsilon hemoglobin antibodies to identify fetal cells |
-
1998
- 1998-07-09 FR FR9809006A patent/FR2781055B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-23 US US09/338,505 patent/US6534279B1/en not_active Expired - Lifetime
- 1999-07-05 EP EP99430012A patent/EP0971233B1/de not_active Expired - Lifetime
- 1999-07-05 DE DE69903380T patent/DE69903380T2/de not_active Expired - Lifetime
- 1999-07-05 DK DK99430012T patent/DK0971233T3/da active
- 1999-07-05 PT PT99430012T patent/PT971233E/pt unknown
- 1999-07-05 ES ES99430012T patent/ES2184399T3/es not_active Expired - Lifetime
- 1999-07-05 AT AT99430012T patent/ATE225936T1/de not_active IP Right Cessation
- 1999-07-07 JP JP11192898A patent/JP2000039433A/ja active Pending
- 1999-07-07 NZ NZ336635A patent/NZ336635A/xx unknown
- 1999-07-08 AU AU39107/99A patent/AU754271B2/en not_active Ceased
- 1999-07-08 NO NO19993380A patent/NO320635B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT971233E (pt) | 2003-02-28 |
| NO993380D0 (no) | 1999-07-08 |
| US6534279B1 (en) | 2003-03-18 |
| JP2000039433A (ja) | 2000-02-08 |
| DK0971233T3 (da) | 2003-02-10 |
| AU3910799A (en) | 2000-02-10 |
| ATE225936T1 (de) | 2002-10-15 |
| AU754271B2 (en) | 2002-11-07 |
| DE69903380D1 (de) | 2002-11-14 |
| FR2781055A1 (fr) | 2000-01-14 |
| FR2781055B1 (fr) | 2000-10-13 |
| NZ336635A (en) | 2000-11-24 |
| NO993380L (no) | 2000-01-10 |
| ES2184399T3 (es) | 2003-04-01 |
| EP0971233B1 (de) | 2002-10-09 |
| EP0971233A1 (de) | 2000-01-12 |
| DE69903380T2 (de) | 2003-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5122453A (en) | Method for discriminating surface stained lymphocytes | |
| EP0161770B1 (de) | Auflösungsmittel zur Bestimmung von peripherischen Blutzellen | |
| US4902613A (en) | Lysing agent for analysis of peripheral blood cells | |
| EP0788605B1 (de) | Nachweiss von antikörper gegen bakterielle antigene durch fluoreszenz-polarisation | |
| Allen et al. | Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia | |
| US6951727B2 (en) | Methods and reagents for quantitation of cell-surface molecule expression on peripheral blood cells | |
| JPH0678792A (ja) | 細胞の固定剤および細胞表面を破壊しないで細胞を染色する方法 | |
| EP0105465B1 (de) | Verfahren zur Herstellung eines mit T-Zell-Leukämie von Erwachsenen assoziierten Antigens | |
| Fejes-Toth et al. | Isolated principal and intercalated cells: hormone responsiveness and Na+-K+-ATPase activity | |
| CA1319592C (en) | Conservative whole blood sample preparation technique | |
| NO320635B1 (no) | Fremgangsmate for permeabilisering og identifisering av erytrocytter og sett for permeabilisering og immunisering derav. | |
| Magnani et al. | Preparation and characterization of biotinylated red blood cells | |
| JP2001506005A (ja) | 細胞の選択的溶解 | |
| Schols et al. | Detection of immediate early, early and late antigens of human cytomegalovirus by flow cytometry | |
| AU592528B2 (en) | Specific binding flow cytometry method | |
| Guest | Use of a phycoerythrin‐conjugated anti‐glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry | |
| Ruckerbauer et al. | V. Detection of the Virus in Infected Materials by Immunofluorescence | |
| JPH1175892A (ja) | マラリア原虫の検出方法 | |
| Arguello-Garcia et al. | Sequential exposure and assembly of cyst wall filaments on the surface of encysting Giardia duodenalis | |
| US5599682A (en) | Method for the protection of leucocytes and method of blood analysis | |
| WO1999024832A1 (en) | Distinguishing of viable, early apoptotic and necrotic cells | |
| US20090035758A1 (en) | Method of Measurement of Micronucleated Erythrocyte Populations | |
| Brenan et al. | Topographical studies of lymphocyte localization using an intracellular fluorochrome | |
| Karlsson et al. | Demonstration of Francisella tularensis (syn. Pasteurella tularensis) in sylvan animals with the aid of fluorescent antibodies | |
| Kamboh et al. | Genetic studies of low-abundance human plasma proteins. I. Microheterogeneity of zinc-α 2-glycoprotein in biological fluids |